The HHS rule, which mandates that health insurers not count copay assistance toward out-of-pocket costs, was struck down last fall, however, it is backfiring on patients with chronic diseases that need expensive drugs.

Bill Snyder, CEO of Vivante Health, discusses the importance of digestive health and its impact on health care spend.

Biden's policies on negotiating lower drug prices are in their early stages, but they are also starting to take effect for a number of drugs in the Medicare program.

Misconduct may be increasing in some industries compared to others that have embraced work from home or hybrid work environments.